ABSTRACT
INTRODUCTION
Color Doppler ultrasonography has proved to be an important addition to the ultrasound armamentarium for the evaluation of the uterus after pregnancy. Postpartum, or after an induced or spontaneous abortion, it is common to see increased vascularity in the endometrium and surrounding myometrium in the presence of retained products of conception (RPOC) . Color Doppler has demonstrated the intense and turbulent appearance of that vascularity, which resembles an arteriovenous malformation (AVM). An AVM is a vascular structural abnormality in which arteries and veins are connected directly rather than through capillaries. This direct connection produces enlarged, tangled vessels creating fast, turbulent flow.
These foci of intense vascularity associated with recent pregnancy have been called acquired AVMs or enhanced myometrial vascularity by some investigators, who recommended that they be treated expectantly or by embolization rather than surgically by dilation and curettage (D&C). The recent literature contains many reports of patients with these acquired postpregnancy 'AVMs', which include warnings that management by D&C might entail a risk of extensive bleeding and need for hysterectomy [1] [2] [3] [4] [5] .
True uterine AVMs are extremely rare and probably have a different pathogenesis from the tangles of large vessels associated with RPOC 1, 6 . Moreover, AVMs may require different treatment protocols from enhanced myometrial vascularity resulting from recent pregnancy.
Several recent reports advocate expectant management for these acquired AVMs associated with RPOC, and demonstrate that these tangles of myometrial vessels can resolve spontaneously over several weeks to months 3, 4 . There is little if any evidence that D&C on patients with enhanced myometrial vascularity associated with RPOC actually causes complications, except in the cases of Cesarean-section scar and molar pregnancies 1, 3, 7 .
We have routinely managed symptomatic patients with RPOC by D&C, even when color Doppler ultrasound demonstrates enhanced myometrial vascularity, because we do not consider these to be equivalent to AVMs. To evaluate this management strategy, which may differ substantially from that employed elsewhere, we performed this study to assess the complication rate resulting from surgical management by D&C of patients with these postpregnancy intensely vascular RPOCs that extend into the myometrium.
METHODS
Institutional review board approval was obtained from the Brigham and Women's Hospital (BWH) Human Research Committee for this study, which was based on retrospective review of medical records. We conducted a search of our database for all patients who presented for ultrasound examination with RPOC and postpregnancy bleeding between 1 August 2015 and 1 August 2017.
The ultrasound images of these patients were then reviewed by two of the authors, and those who had an area of enhanced myometrial vascularity associated with RPOC were included in the study group. The widest dimension of the region of intense myometrial vascularity was measured on the reviewed images and tabulated. The vascularity was noted to be marked, due to a large amount of turbulent blood flow extending from the endometrial mass into the myometrium, as seen on color Doppler, an appearance similar to that referred to as 'acquired AVMs' by other authors. The scans were performed transvaginally using GE Voluson E8 (GE Medical Systems, Zipf, Austria) ultrasound equipment with a 6-9-MHz transducer. Color/power Doppler imaging was used subjectively in our ultrasound unit to identify the degree and extent of vascularity; therefore, no spectral Doppler data were obtained.
The medical records of the patients whose RPOCs were managed at the BWH were reviewed. The operative reports were obtained by reviewing the hospital electronic medical records. Estimated blood loss, postoperative complications and final outcome were tabulated.
RESULTS
The study group included 31 patients, all of whom ultimately underwent D&C for the treatment of RPOC (Table S1 ). Seven patients had RPOC after vaginal delivery and 24 following a first-trimester termination or miscarriage. The largest width of the region of enhanced myometrial vascularity varied from 10 mm to 53 mm, with 14/31 cases having a width of ≥ 20 mm (Figures 1-4) .
Seven patients had had failed treatment for RPOC with misoprostol before the ultrasound diagnosis of RPOC and enhanced myometrial vascularity. Three patients had already undergone a D&C procedure for RPOC when they presented to our ultrasound unit and received the diagnosis of persistent RPOC and enhanced myometrial vascularity, and two patients had had both a prior D&C as well as one or two courses of misoprostol before presenting for the ultrasound examination.
All 31 patients underwent D&C evacuation of the RPOC. The surgery was performed from 0 days to 30 days (average, 4 days) after the ultrasound examination that showed the area of enhanced myometrial vascularity and RPOC. Fifteen (48%) patients underwent standard D&C, whereas in 13 patients the procedure was performed under direct ultrasound guidance, and three patients had hysteroscopy to ensure complete removal of the RPOC. Blood loss varied from negligible to a maximum of 400 mL. Only three patients had blood loss estimated at >100 mL and none required intraoperative or postoperative treatment for bleeding. There were no surgical complications, although one patient was treated 15 days postoperatively for presumed endometritis.
DISCUSSION
A number of reports describe acquired AVMs interchangeably with enhanced areas of myometrial vascularity associated with recent pregnancy, that display notable turbulent and high-velocity flow in a tangle of vessels extending into the myometrium [2] [3] [4] [5] [6] [7] . Retained placental tissue is the probable cause of the 'AVM-like' appearance demonstrated by Doppler ultrasound in these patients 8, 9 . Several recent reports advocate embolization as the first-line treatment, and recommend avoiding surgical intervention owing to the risk of hemorrhage 2, 3 . All our patients were treated with D&C and none of them required embolization. Surgical management of RPOCs associated with enhanced myometrial vascularity on color Doppler was not associated with excessive blood loss requiring transfusion or any serious complications in our cohort.
Uterine-artery embolization requires radiation and insertion of foreign bodies, and has multiple potential complications, in addition to which the potential deleterious effect of the procedure on future reproduction and other outcomes remains uncertain [10] [11] [12] . In the largest study to date describing patients with abnormally enhanced myometrial vascularity after pregnancy, Timor-Tritsch et al. 3 reported on 27 patients diagnosed with what they refer to as 'pregnancy-related enhanced myometrial vascularity/AVM', eight of whom underwent treatment with uterine-artery embolization. Their cohort included five cases of Cesarean scar pregnancy, which presents a greater management challenge and risk than do lesions of similar appearance occurring following normally located pregnancy. Uncontrollable hemorrhage requiring hysterectomy occurred in only two patients, both of whom had a Cesarean scar pregnancy. For this reason, we excluded abnormally located pregnancies from our retrospective cohort. In the study of Timor-Tritsch et al., 13/27 patients had serial imaging and expectant management with ultimate resolution of the abnormal vascularity over 2-15 weeks 3 . Our data suggest that a management strategy of D&C is a safe treatment method and will prevent the need for uterine-artery embolization in these patients.
Timmerman et al. 5 reported the utility of spectral Doppler to differentiate patients with high velocity flow, defined as peak systolic velocity (PSV) above the threshold of 83 cm/s, in their myometrial hypervascular area, in view of a perceived increased risk of bleeding and other complications in such cases. The eight patients with PSV > 83 cm/s underwent selective uterine-artery embolization rather than D&C. Subsequently, the same group studied specifically patients with PSV > 60 cm/s and found that D&C could be performed safely to evacuate the POC, with subsequent resolution of the enhanced myometrial vascularity in patients with high PSV 7 . They reported that the patient with the highest PSV -of 152.6 cm/s -had a blood loss of 200 mL at D&C, similar to the blood loss of one of our patients. These studies suggest that measurement of PSV would not affect management; hence, it is not included in our protocol.
Most cases of enhanced myometrial vascularity result from retained placental tissue and are not true AVMs. D&C most often results in complete removal of these RPOCs, resolution of vaginal bleeding and quick resolution of the enhanced myometrial vascularity 7 . In our experience, when the vascularity persists, it is often because not all the retained tissue has been removed, resulting in persistent bleeding. In half of the cases reported in this study, transabdominal ultrasound guidance or hysteroscopy was used during the surgical evacuation of the POC. It is likely that the use of such imaging guidance enhanced the success of complete surgical removal of the RPOC.
Limitations of this study include its retrospective design and the limited sample size, which cannot exclude a complication rate below approximately 1:30, although this is the largest series of this entity reported to date. The inclusion of only pregnancies with normal location in the uterus (exclusion of Cesarean scar pregnancies) probably enhances the likelihood of a good outcome, and is an example of management based on individual patient characteristics.
In conclusion, our data indicate that D&C with ultrasound guidance can be a safe and acceptable method for treating patients with excessive vascularity associated with RPOC. Furthermore, we have not found it necessary to measure PSV, since that measurement does not appear to add clinically actionable information nor does it change management of these cases. Despite its retrospective nature and limited number of patients, this is the largest series of this kind in the literature to date. Our exclusion of abnormally located pregnancies probably contributed to the lack of adverse outcomes in this cohort; this selection illustrates a 'personalized' or 'precision' approach to management based on patient characteristics that may avoid unnecessary invasive radiologic procedures and imaging.
